LAUREN DOBSON: Open Payments
NPI 1306536842 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 32 payments from 15 companies in 2025. Trend: 2023 $201 · 2024 $421 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $83 |
| Amgen Inc. | 5 | $78 |
| Novo Nordisk Inc | 5 | $77 |
| ABBVIE INC. | 4 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Verona Pharma, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
Products named: EVENITY, JARDIANCE, REXULTI, VRAYLAR, Ozempic, Wegovy, SPRAVATO, JOURNAVX.
Industry payments across NE — which companies pay providers there.
